Straits Times Index
3,322.62 +14.72 (+0.45%) S&P 500
5,307.01 -14.40 (-0.27%) Dow
39,671.04 -201.95 (-0.51%) Nasdaq
16,801.54 -31.08 (-0.18%) Bitcoin USD
69,883.77 +29.53 (+0.04%) CMC Crypto 200
1,513.91 +11.25 (+0.75%)
Creative Medical Technology Holdings, Inc. (CELZ)
Pre-market:
- Business Wire
Creative Medical Technology Holdings Provides Corporate Update
PHOENIX, March 27, 2024--Creative Medical Technology Holdings, Inc., ("Creative Medical Technology" or the "Company") (NASDAQ: CELZ), a biotechnology company focused on a regenerative approach to immunotherapy, endocrinology, urology, gynecology, and orthopedics, today provided a corporate update in connection with the filing of its Form 10-K on March 22, 2024.
- Simply Wall St.
Creative Medical Technology Holdings Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags
Creative Medical Technology Holdings ( NASDAQ:CELZ ) Full Year 2023 Results Key Financial Results Net loss: US$5.29m...
- Business Wire
Creative Medical Technology Holdings Inc. Announces FDA Authorization for Groundbreaking Type 1 Diabetes Prevention Therapy Under Expanded Access
PHOENIX, March 07, 2024--Creative Medical Technology Holdings, Inc., (NASDAQ:CELZ), a leader in biotech innovation, today announced a major stride in combating Type 1 Diabetes Mellitus (T1D). The company has secured FDA authorization for an expanded access therapy using CELZ-201, a pioneering cell-based program in managing abnormal glucose tolerance and preventing T1D in high-risk individuals.
